共 50 条
- [2] Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-confined Muscle-invasive Bladder CancerUROLOGY, 2017, 102 : 148 - 157Chappidi, Meera R.Kates, MaxBrant, AaronBaras, Alexander S.Netto, George J.Pierorazio, Phillip M.Hahn, Noah M.Bivalacqua, Trinity J.
- [3] Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-confined Muscle-invasive Bladder Cancer REPLYUROLOGY, 2017, 102 : 158 - 158Chappidi, Meera R.Kates, MaxBivalacqua, Trinity J.
- [4] ASSESSING CANCER PROGRESSION AND STABLE DISEASE AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCERJOURNAL OF UROLOGY, 2016, 195 (04): : E666 - E666Chappidi, MeeraKates, MaxBrant, AaronBaras, AlexanderNetto, GeorgeHahn, NoahPierorazio, PhillipSchoenberg, MarkBivalacqua, Trinity
- [5] Re: Radiotherapy With or Without Chemotherapy in Muscle-Invasive Bladder Cancer Editorial CommentJOURNAL OF UROLOGY, 2012, 188 (06): : 2151 - 2151Wood, David P.
- [6] Re: Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer CommentJOURNAL OF UROLOGY, 2021, 205 (06): : 1822 - 1822Chang, Sam S.
- [7] Re: Impact of Molecular Subtypes in Muscle-Invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy Editorial CommentJOURNAL OF UROLOGY, 2018, 200 (06): : 1163 - 1163Chang, Sam S.
- [8] Radical Transurethral Resection of Bladder Tumor in Organ-confined Muscle-invasive Bladder Cancer: Yes!EUROPEAN UROLOGY FOCUS, 2023, 9 (02): : 225 - 226Wood, Erika L.Djaladat, Hooman
- [9] Re: Predicting the Pathologic Complete Response after Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer Editorial CommentJOURNAL OF UROLOGY, 2022, 207 (05): : 1154 - 1155Chang, Sam S.
- [10] Re: Cost-Effectiveness of Neoadjuvant Chemotherapy before Radical Cystectomy for Muscle-Invasive Bladder Cancer Editorial CommentJOURNAL OF UROLOGY, 2016, 195 (06): : 1720 - 1721Chang, Sam S.